FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA) since 2004. Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest Drug Approvals
- Nocdurna (desmopressin acetate) - June 21, 2018
- (moxidectin) - June 13, 2018
- Fulphila (pegfilgrastim-jmdb) - June 04, 2018
- Consensi (amlodipine and celecoxib) - May 31, 2018
- Olumiant (baricitinib) - May 31, 2018
- Imvexxy (estradiol) - May 29, 2018
- Palynziq (pegvaliase-pqpz) - May 24, 2018
- Yonsa (abiraterone acetate) - May 22, 2018
- Doptelet (avatrombopag) - May 21, 2018
- Lokelma (sodium zirconium cyclosilicate) - May 18, 2018
- Aimovig (erenumab-aooe) - May 17, 2018
- Lucemyra (lofexidine hydrochloride) - May 16, 2018
- Retacrit (epoetin alfa-epbx) - May 15, 2018
- Plenvu (polyethylene glycol 3350 with electrolytes) - May 04, 2018
- Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) - May 03, 2018
- Jynarque (tolvaptan) - April 23, 2018
- Akynzeo for Injection (fosnetupitant and palonosetron) - April 19, 2018
- Crysvita (burosumab-twza) - April 17, 2018
- Tavalisse (fostamatinib) - April 17, 2018
- Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) - March 22, 2018
